Target intelligence / Profile preview

Immunocompetent cell

Molecular classification
Other
01

Overview

An immunocompetent cell is a cell that has the capacity to develop an immune response following exposure to an antigen (StatPearls, 2023). This category primarily includes lymphocytes such as T cells, B cells, and natural killer (NK) cells, as well as professional antigen-presenting cells like dendritic cells and macrophages (NCI Dictionary, 2024). The primary biological function of these cells is to maintain host defense by identifying and neutralizing foreign pathogens and performing immunosurveillance against malignant cells (Abbas et al., Cellular and Molecular Immunology, 2021). Dysregulation of immunocompetent cells is a hallmark of autoimmune diseases, where they attack self-tissues, and chronic inflammatory conditions (PubMed, PMID: 31434123). While the term refers to a broad cell population rather than a specific molecular target, these cells are the primary site of action for many immunomodulatory and immuno-oncology therapies. Drugs interact with these cells by targeting specific surface receptors or signaling pathways, such as PD-1 on T cells or CD20 on B cells, to either enhance or suppress immune activity (Nature Reviews Drug Discovery, 2020). Monitoring the status and function of these cells is critical for assessing immune health and treatment efficacy in clinical settings.

Other names
Immune cellImmunocyteLeukocyteAntigen-responsive cell
02

Mechanism of action

Immunomodulation via binding to specific cell-surface receptors, inhibition of intracellular signaling pathways, or neutralization of cytokines.

03

Biological functions

Immune responseAntigen recognitionCell-mediated immunityHumoral immunityPhagocytosis
04

Disease associations

Autoimmune diseaseCancerInfectionInflammationImmunodeficiency
05

Safety considerations

Increased risk of infectionSecondary malignanciesCytokine release syndromeAutoimmune-related adverse events
06

Interacting drugs

Cyclosporine

4 more in the full profile.

07

Biomarkers

CD4+ T-cell countCD8+ T-cell countAbsolute lymphocyte countCytokine expression profiles

Beyond the preview

Go deeper on Immunocompetent cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunocompetent cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call